{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:22:14Z","timestamp":1774999334725,"version":"3.50.1"},"reference-count":176,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100007161","name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado del Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20210756"],"award-info":[{"award-number":["20210756"]}],"id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["COS"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Benzimidazole (BI) and its derivatives are interesting molecules in medicinal\nchemistry because several of these compounds have a diversity of biological activities and some\nof them are even used in clinical applications. In view of the importance of these compounds,\nsynthetic chemists are still interested in finding new procedures for the synthesis of these classes\nof compounds. Astemizole (antihistaminic), Omeprazole (antiulcerative), and Rabendazole\n(fungicide) are important examples of compounds used in medicinal chemistry containing BI\nnuclei. It is interesting to observe that several of these compounds contain 2-aminobenzimidazole\n(2ABI) as the base nucleus. The structures of 2ABI derivatives are interesting because they have\na planar delocalized structure with a cyclic guanidine group, which have three nitrogen atoms\nwith free lone pairs and labile hydrogen atoms. The 10-\u03c0 electron system of the aromatic BI ring\nconjugated with the nitrogen lone pair of the hexocyclic amino group, making these heterocycles\nto have an amphoteric character. Synthetic chemists have used 2ABI as a building block to\nproduce BI derivatives as medicinally important molecules. In view of the importance of the BIs,\nand because no review was found in the literature about this topic, we reviewed and summarized\nthe procedures related to the recent methodologies used in the N-substitution reactions of 2ABIs\nby using aliphatic and aromatic halogenides, dihalogenides, acid chlorides, alkylsulfonic\nchlorides, carboxylic acids, esters, ethyl chloroformates, anhydrides, SMe-isothioureas, alcohols,\nalkyl cyanates, thiocyanates, carbon disulfide and aldehydes or ketones to form Schiff bases. The\nuse of diazotized 2ABI as intermediate to obtain 2-diazoBIs was included to produce Nsubstituted\n2ABIs of pharmacological interest. Some commentaries about their biological activity\nwere included.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570179419666220310124223","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T05:47:20Z","timestamp":1646977640000},"page":"177-219","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["N-substitution Reactions of 2-Aminobenzimidazoles to Access Pharmacophores"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6255-9112","authenticated-orcid":true,"given":"Alejandro","family":"Cruz","sequence":"first","affiliation":[{"name":"Laboratorio de Qu\u00edmica Supramolecular y Nanociencias, Instituto Polit\u00e9cnico Nacional UPIBI, Av. Acueducto s\/n,\nBarrio la Laguna Ticom\u00e1n, Ciudad de M\u00e9xico, 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-2049","authenticated-orcid":true,"given":"Itzia I.","family":"Padilla-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Laboratorio de Qu\u00edmica Supramolecular y Nanociencias, Instituto Polit\u00e9cnico Nacional UPIBI, Av. Acueducto s\/n,\nBarrio la Laguna Ticom\u00e1n, Ciudad de M\u00e9xico, 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-7385","authenticated-orcid":true,"given":"Efr\u00e9n V.","family":"Garc\u00eda-B\u00e1ez","sequence":"additional","affiliation":[{"name":"Laboratorio de Qu\u00edmica Supramolecular y Nanociencias, Instituto Polit\u00e9cnico Nacional UPIBI, Av. Acueducto s\/n,\nBarrio la Laguna Ticom\u00e1n, Ciudad de M\u00e9xico, 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha C.","family":"Rosales-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biof\u00edsica y Biocat\u00e1lisis, Secci\u00f3n de\nEstudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Plan de San Luis y\nSalvador D\u00edaz Mir\u00f3n s\/n, Casco de Santo Tom\u00e1s, Distrito Federal 11340, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Mendieta Wejebe","sequence":"additional","affiliation":[{"name":"Laboratorio de Biof\u00edsica y Biocat\u00e1lisis, Secci\u00f3n de\nEstudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Plan de San Luis y\nSalvador D\u00edaz Mir\u00f3n s\/n, Casco de Santo Tom\u00e1s, Distrito Federal 11340, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1"},{"key":"ref=1a","first-page":"78","volume":"4","author":"Enumula S.","year":"2014","unstructured":"Enumula S.; Pangal A.; Gazge M.; Javed A.; Shaikh J.A.; Ahmed K.; Diverse pharmacological aspects of benzimidazole derivatives: A review. Res J Chem Sci 2014,4,78-88","journal-title":"Res J Chem Sci"},{"key":"ref=1b","doi-asserted-by":"publisher","first-page":"28","DOI":"10.9790\/3013-0401201028041","volume":"4","author":"Srestha N.","year":"2014","unstructured":"Srestha N.; Banerjee J.; Srivastava S.; A review on chemistry and biological significance of benzimidazole nucleus. IOSR J Pharm 2014,4(12),28-41","journal-title":"IOSR J Pharm"},{"key":"ref=1c","first-page":"109","volume":"2","author":"Yerragunta V.","year":"2014","unstructured":"Yerragunta V.; Patil P.; Srujana S.; Devi R.; Srujana G.R.; Divya A.; Benzimidazole derivatives and its biological importance: A review. PharmaTutor 2014,2,109-113","journal-title":"PharmaTutor"},{"key":"ref=1d","first-page":"47","volume":"6","author":"Hamiduzzaman M.","year":"2014","unstructured":"Hamiduzzaman M.; Mannan S.J.; Dey A.; Rahman S.M.A.; Evaluation of analgesic, antipyretic, hypoglycemic and CNS depressant activity of 2-bromopopylamine hydrobromide, 3-bromopopyl ammonium bromide, ortho-amino aniline and benzimidazole-2-thiol in animal model. Der Pharm Lett 2014,6,47-53","journal-title":"Der Pharm Lett"},{"key":"ref=1e","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1570193X1202150225153403","volume":"12","author":"Arulmurugan S.","year":"2015","unstructured":"Arulmurugan S.; Kavitha H.P.; Sathishkumar S.; Arulmozhi R.; Biologically active benzimidazole derivatives. Mini Rev Org Chem 2015,12,178-195","journal-title":"Mini Rev Org Chem"},{"key":"ref=1f","first-page":"60","volume":"8","author":"Naga P.K.","year":"2015","unstructured":"Naga P.K.; Kumar K.R.; Green synthesis of benzimidazole derivatives: An overview of bulk drug synthesis. Int J Pharm Tech Res 2015,8,60-68","journal-title":"Int J Pharm Tech Res"},{"key":"ref=1g","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2015.05.021","volume":"99","author":"Wang Y-T.","year":"2015","unstructured":"Wang Y-T.; Qin Y-J.; Yang N.; Zhang Y-L.; Liu C.H.; Zhu H.L.; Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Eur J Med Chem 2015,99,125-137","journal-title":"Eur J Med Chem"},{"key":"ref=1h","doi-asserted-by":"publisher","first-page":"15206","DOI":"10.3390\/molecules200815206","volume":"20","author":"Alasmary F.A.","year":"2015","unstructured":"Alasmary F.A.; Snelling A.M.; Zain M.E.; Alafeefy A.M.; Awaad A.S.; Karodia N.; Karodia N.; Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents. Molecules 2015,20(8),15206-15223","journal-title":"Molecules"},{"key":"ref=1i","doi-asserted-by":"publisher","first-page":"50384","DOI":"10.1039\/C6RA06930D","volume":"6","author":"Maiti B.","year":"2016","unstructured":"Maiti B.; Chanda K.; Diversity oriented synthesis of benzimidazole-based biheterocyclic molecules by combinatorial approach: A critical review. RSC Advances 2016,6(56),50384-50413","journal-title":"RSC Advances"},{"key":"ref=1j","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.pharep.2016.08.002","volume":"68","author":"Keri R.S.","year":"2016","unstructured":"Keri R.S.; Rajappa C.K.; Patil S.A.; Nagaraja B.M.; Benzimidazole-core as an antimycobacterial agent. Pharmacol Rep 2016,68(6),1254-1265","journal-title":"Pharmacol Rep"},{"key":"ref=1k","first-page":"19","volume":"5","author":"Aishwarya M.N.L.","year":"2017","unstructured":"Aishwarya M.N.L.; Rao E.A.; Babu M.N.; A review on gastrointestinal drug esomeprazole. Pharm Tutor 2017,5,19-26","journal-title":"Pharm Tutor"},{"key":"ref=1l","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1570179413666160818151932","volume":"14","author":"Rajasekhar S.","year":"2017","unstructured":"Rajasekhar S.; Maiti B.; Balamurali M.M.; Chanda K.; Synthesis and medicinal applications of benzimidazoles: An overview. Curr Org Synth 2017,14,40-60","journal-title":"Curr Org Synth"},{"key":"ref=2a","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/030006059702500401","volume":"25","author":"al-Muhaimeed H.","year":"1997","unstructured":"al-Muhaimeed H.; A parallel-group comparison of astemizole and loratadine for the treatment of perennial allergic rhinitis. J Int Med Res 1997,25(4),175-181","journal-title":"J Int Med Res"},{"key":"ref=2b","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1081\/SCC-120028643","volume":"34","author":"Ramalingan C.","year":"2004","unstructured":"Ramalingan C.; Balasubramanian S.; Kabilan S.; A convenient synthesis of novel 1\u2010[2\u2010(Benzimidazol\u20102\u2010yl)ethoxy]\u20102,6\u2010diarylpiperidin\u20104\u2010ones. Synth Commun 2004,34(6),1105-1116","journal-title":"Synth Commun"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00044-015-1495-5","volume":"25","author":"Gaba M.","year":"2016","unstructured":"Gaba M.; Mohan C.; Development of drugs based on imidazole and benzimidazole bioactive heterocycles: Recent advances and future directions. Med Chem Res 2016,25(2),173-210","journal-title":"Med Chem Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3998\/ark.5550190.0004.e16","volume":"xiv","author":"Wahe H.","year":"2003","unstructured":"Wahe H.; Asobo P.F.; Cherkasov R.A.; Nkengfack A.E.; Folefoc G.N.; Forum Z.T.; Doepp D.; Heterocycles of biological importance. part 6. the formation of novel biologically active pyrimido [1,2-a]benzimidazoles from electron deficient alkynes and 2-aminobenzimidazoles. ARKIVOC 2003,xiv(14),170-177","journal-title":"ARKIVOC"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.bmcl.2004.04.005","volume":"14","author":"Beaulieu C.","year":"2004","unstructured":"Beaulieu C.; Wang Z.; Denis D.; Greig G.; Lamontagne S.; O\u2019Neill G.; Slipetz D.; Wang J.; Benzimidazoles as new potent and selective dp antagonists for the treatment of allergic rhinitis. Bioorg Med Chem Lett 2004,14(12),3195-3199","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=6a","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1021\/jm00150a028","volume":"28","author":"Janssens F.","year":"1985","unstructured":"Janssens F.; Torremans J.; Janssen M.; Stokbroekx R.A.; Luyckx M.; Janssen P.A.; New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines. J Med Chem 1985,28(12),1925-1933","journal-title":"J Med Chem"},{"key":"ref=6b","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bmc.2003.11.030","volume":"12","author":"Mor M.","year":"2004","unstructured":"Mor M.; Bordi F.; Silva C.; Rivara S.; Zuliani V.; Vacondio F.; Rivara M.; Barocelli E.; Bertoni S.; Ballabeni V.; Magnanini F.; Impicciatore M.; Plazzi P.V.; Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Bioorg Med Chem 2004,12(4),663-674","journal-title":"Bioorg Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1521-4184(199807)331:7\/8<249::AID-ARDP249>3.0.CO;2-B","volume":"331","author":"Nawrocka W.","year":"1998","unstructured":"Nawrocka W.; Zimecki M.; Synthesis and immunotropic activity of some 2-aminobenzimidazoles, Part 4. Arch Pharm (Weinheim) 1998,331(7-8),249-253","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00044-017-2036-1","volume":"27","author":"Sethi P.","year":"2018","unstructured":"Sethi P.; Bansal Y.; Bansal G.; Synthesis and pass-assisted evaluation of coumarin-benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents. Med Chem Res 2018,27(1),61-71","journal-title":"Med Chem Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1021\/jm800318d","volume":"51","author":"Charifson P.S.","year":"2008","unstructured":"Charifson P.S.; Grillot A-L.; Grossman T.H.; Parsons J.D.; Badia M.; Bellon S.; Deininger D.D.; Drumm J.E.; Gross C.H.; LeTiran A.; Liao Y.; Mani N.; Nicolau D.P.; Perola E.; Ronkin S.; Shannon D.; Swenson L.L.; Tang Q.; Tessier P.R.; Tian S.K.; Trudeau M.; Wang T.; Wei Y.; Zhang H.; Stamos D.; Stamos D.; Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: Intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. J Med Chem 2008,51(17),5243-5263","journal-title":"J Med Chem"},{"key":"ref=10a","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2004.04.007","volume":"64","author":"Middleton T.","year":"2004","unstructured":"Middleton T.; Lim H.B.; Montgomery D.; Rockway T.; Tang H.; Cheng X.; Lu L.; Mo H.; Kohlbrenner W.E.; Molla A.; Kati W.M.; Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. Antiviral Res 2004,64(1),35-45","journal-title":"Antiviral Res"},{"key":"ref=10b","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/med.20054","volume":"26","author":"Dayam R.","year":"2006","unstructured":"Dayam R.; Deng J.; Neamati N.; HIV-1 integrase inhibitors: 2003-2004 update. Med Res Rev 2006,26(3),271-309","journal-title":"Med Res Rev"},{"key":"ref=11a","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0968-0896(02)00616-8","volume":"11","author":"Kling A.","year":"2003","unstructured":"Kling A.; Backfisch G.; Delzer J.; Geneste H.; Graef C.; Hornberger W.; Lange U.E.; Lauterbach A.; Seitz W.; Subkowski T.; Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists. Bioorg Med Chem 2003,11(7),1319-1341","journal-title":"Bioorg Med Chem"},{"key":"ref=11b","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1021\/jm070790o","volume":"50","author":"Carpenter R.D.","year":"2007","unstructured":"Carpenter R.D.; Andrei M.; Lau E.Y.; Lightstone F.C.; Liu R.; Lam K.S.; Kurth M.J.; Highly potent, water soluble benzimidazole antagonist for activated &#x3B1; 4 &#x3B2; 1 integrin. J Med Chem 2007,50(23),5863-5867","journal-title":"J Med Chem"},{"key":"ref=12a","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1021\/jm020113o","volume":"45","author":"Snow R.J.","year":"2002","unstructured":"Snow R.J.; Cardozo M.G.; Morwick T.M.; Busacca C.A.; Dong Y.; Eckner R.J.; Jacober S.; Jakes S.; Kapadia S.; Lukas S.; Panzenbeck M.; Peet G.W.; Peterson J.D.; Prokopowicz A.S.; Sellati R.; Tolbert R.M.; Tschantz M.A.; Moss N.; Discovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: A new class of inhibitors of lck kinase. J Med Chem 2002,45(16),3394-3405","journal-title":"J Med Chem"},{"key":"ref=12b","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1016\/j.bmcl.2009.07.016","volume":"19","author":"Zhong M.","year":"2009","unstructured":"Zhong M.; Bui M.; Shen W.; Baskaran S.; Allen D.A.; Elling R.A.; Flanagan W.M.; Fung A.D.; Hanan E.J.; Harris S.O.; Heumann S.A.; Hoch U.; Ivy S.N.; Jacobs J.W.; Lam S.; Lee H.; McDowell R.S.; Oslob J.D.; Purkey H.E.; Romanowski M.J.; Silverman J.A.; Tangonan B.T.; Taverna P.; Yang W.; Yoburn J.C.; Yu C.H.; Zimmerman K.M.; O\u2019Brien T.; Lew W.; 2-Aminobenzimidazoles as potent Aurora kinase inhibitors. Bioorg Med Chem Lett 2009,19(17),5158-5161","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=12c","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bmcl.2008.11.056","volume":"19","author":"Cee V.J.","year":"2009","unstructured":"Cee V.J.; Cheng A.C.; Romero K.; Bellon S.; Mohr C.; Whittington D.A.; Bak A.; Bready J.; Caenepeel S.; Coxon A.; Deak H.L.; Fretland J.; Gu Y.; Hodous B.L.; Huang X.; Kim J.L.; Lin J.; Long A.M.; Nguyen H.; Olivieri P.R.; Patel V.F.; Wang L.; Zhou Y.; Hughes P.; Geuns-Meyer S.; Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase. Bioorg Med Chem Lett 2009,19(2),424-427","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"15700","DOI":"10.1021\/ja038025w","volume":"125","author":"Fujita M.","year":"2003","unstructured":"Fujita M.; Nakao Y.; Matsunaga S.; Seiki M.; Itoh Y.; Yamashita J.; Van Soest R.W.M.; Fusetani N.; Ageladine A.; Ageladine a: An antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge agelas nakamurai. J Am Chem Soc 2003,125(51),15700-15701","journal-title":"J Am Chem Soc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","volume":"20","author":"Bansal Y.","year":"2012","unstructured":"Bansal Y.; Silakari O.; The therapeutic journey of benzimidazoles: A review. Bioorg Med Chem 2012,20(21),6208-6236","journal-title":"Bioorg Med Chem"},{"key":"ref=15a","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1021\/jm900414x","volume":"52","author":"Mpamhanga C.P.","year":"2009","unstructured":"Mpamhanga C.P.; Spinks D.; Tulloch L.B.; Shanks E.J.; Robinson D.A.; Collie I.T.; Fairlamb A.H.; Wyatt P.G.; Frearson J.A.; Hunter W.N.; Gilbert I.H.; Brenk R.; One scaffold, three binding modes: Novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening. J Med Chem 2009,52(14),4454-4465","journal-title":"J Med Chem"},{"key":"ref=15b","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0960-894X(02)00034-3","volume":"12","author":"Bharti N.","year":"2002","unstructured":"Bharti N.; Shailendra M.T.; Gonzalez Garza M.T.; Cruz-Vega D.E.; Castro-Garza J.; Saleem K.; Naqvi F.; Maurya M.R.; Azam A.; Synthesis, characterization and antiamoebic activity of benzimidazole derivatives and their vanadium and molybdenum complexes. Bioorg Med Chem Lett 2002,12(6),869-871","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=15c","first-page":"689","volume":"43","author":"Ravina E.","year":"1993","unstructured":"Ravina E.; Sanchez-Alonso R.; Fueyo J.; Baltar M.P.; Bos J.; Iglesias R.; Sanmartin M.L.; Synthesis and potential anthelmintic activity of methyl-5-(4-salicyloyl-piperazin-1-yl)-benzimidazole-2-carbamates. Arzneimittelforschung 1993,43(6),689-694","journal-title":"Arzneimittelforschung"},{"key":"ref=16a","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1039\/b700206h","volume":"24","author":"Weinreb S.M.","year":"2007","unstructured":"Weinreb S.M.; Some recent advances in the synthesis of polycyclic imidazole-containing marine natural products. Nat Prod Rep 2007,24(5),931-948","journal-title":"Nat Prod Rep"},{"key":"ref=16b","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/np0305223","volume":"67","author":"Hassan W.","year":"2004","unstructured":"Hassan W.; Edrada R.; Ebel R.; Wray V.; Berg A.; van Soest R.; Wiryowidagdo S.; Proksch P.; New imidazole alkaloids from the Indonesian sponge Leucetta chagosensis. J Nat Prod 2004,67(5),817-822","journal-title":"J Nat Prod"},{"key":"ref=16c","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/138955706775197839","volume":"6","author":"Kamal A.","year":"2006","unstructured":"Kamal A.; Reddy K.L.; Devaiah V.; Shankaraiah N.; Rao M.V.; Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures. Mini Rev Med Chem 2006,6(1),71-89","journal-title":"Mini Rev Med Chem"},{"key":"ref=16d","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2174\/1385272823666191023150201","volume":"23","author":"Cruz A.","year":"2019","unstructured":"Cruz A.; Padilla-Mart&#xED;nez I.I.; Ramos-Organillo A.A.; Methods to access 2-aminobenzimidazoles of medicinal interest. Curr Org Chem 2019,23(23),2573-2597","journal-title":"Curr Org Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1021\/jm048978k","volume":"48","author":"de Dios A.","year":"2005","unstructured":"de Dios A.; Shih C.; L&#xF3;pez de Uralde B.; S&#xE1;nchez C.; del Prado M.; Mart&#xED;n Cabrejas L.M.; Pleite S.; Blanco-Urgoiti J.; Lorite M.J.; Nevill C.R.; Bonjouklian R.; York J.; Vieth M.; Wang Y.; Magnus N.; Campbell R.M.; Anderson B.D.; McCann D.J.; Giera D.D.; Lee P.A.; Schultz R.M.; Li L.C.; Johnson L.M.; Wolos J.A.; Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy. J Med Chem 2005,48(7),2270-2273","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1021\/acs.jmedchem.5b01586","volume":"59","author":"El Maatougui A.","year":"2016","unstructured":"El Maatougui A.; Azuaje J.; Gonz&#xE1;lez-G&#xF3;mez M.; Miguez G.; Crespo A.; Carbajales C.; Escalante L.; Garc&#xED;a-Mera X.; Guti&#xE9;rrez-de-Ter&#xE1;n H.; Sotelo E.; Discovery of potent and highly selective A2B adenosine receptor antagonist chemotypes. J Med Chem 2016,59(5),1967-1983","journal-title":"J Med Chem"},{"key":"ref=19a","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/AAC.01418-09","volume":"54","author":"Rogers S.A.","year":"2010","unstructured":"Rogers S.A.; Huigens R.W.; Cavanagh J.; Melander C.; Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother 2010,54(5),2112-2118","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=19b","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1039\/c001479f","volume":"8","author":"Su Z.","year":"2010","unstructured":"Su Z.; Rogers S.A.; McCall W.S.; Smith A.C.; Ravishankar S.; Mullikin T.; Melander C.; A nitroenolate approach to the synthesis of 4,5-disubstituted-2-aminoimidazoles. Pilot library assembly and screening for antibiotic and antibiofilm activity. Org Biomol Chem 2010,8(12),2814-2822","journal-title":"Org Biomol Chem"},{"key":"ref=19c","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bmc.2009.12.003","volume":"18","author":"Huigens R.W.","year":"2010","unstructured":"Huigens R.W.; Reyes S.; Reed C.S.; Bunders C.; Rogers S.A.; Steinhauer A.T.; Melander C.; The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii. Bioorg Med Chem 2010,18(2),663-674","journal-title":"Bioorg Med Chem"},{"key":"ref=19d","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1002\/anie.201109258","volume":"51","author":"Frei R.","year":"2012","unstructured":"Frei R.; Breitbach A.S.; Blackwell H.E.; 2-Aminobenzimidazole derivatives strongly inhibit and disperse Pseudomonas aeruginosa biofilms. Angew Chem Int Ed Engl 2012,51(21),5226-5229","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.1021\/bi801136q","volume":"47","author":"Cl&#xE9;ment M.J.","year":"2008","unstructured":"Cl&#xE9;ment M.J.; Rathinasamy K.; Adjadj E.; Toma F.; Curmi P.A.; Panda D.; Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: Evidence of distinct binding sites for these agents in tubulin. Biochemistry 2008,47(49),13016-13025","journal-title":"Biochemistry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1124\/jpet.108.143537","volume":"328","author":"Yenjerla M.","year":"2009","unstructured":"Yenjerla M.; Cox C.; Wilson L.; Jordan M.A.; Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics. J Pharmacol Exp Ther 2009,328(2),390-398","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=22a","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1039\/c003732j","volume":"8","author":"Zhao Y.","year":"2010","unstructured":"Zhao Y.; Pourgholami M.H.; Morris D.L.; Collins J.G.; Day A.I.; Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril. Org Biomol Chem 2010,8(14),3328-3337","journal-title":"Org Biomol Chem"},{"key":"ref=22b","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1182\/blood-2009-09-243055","volume":"115","author":"Spagnuolo P.A.","year":"2010","unstructured":"Spagnuolo P.A.; Hu J.; Hurren R.; Wang X.; Gronda M.; Sukhai M.A.; Di Meo A.; Boss J.; Ashali I.; Beheshti Zavareh R.; Fine N.; Simpson C.D.; Sharmeen S.; Rottapel R.; Schimmer A.D.; The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood 2010,115(23),4824-4833","journal-title":"Blood"},{"key":"ref=22c","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/CAD.0b013e328330e74e","volume":"21","author":"Laryea D.","year":"2010","unstructured":"Laryea D.; Gullbo J.; Isaksson A.; Larsson R.; Nygren P.; Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells. Anticancer Drugs 2010,21(1),33-42","journal-title":"Anticancer Drugs"},{"key":"ref=22d","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","volume":"6","author":"Doudican N.","year":"2008","unstructured":"Doudican N.; Rodriguez A.; Osman I.; Orlow S.J.; Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol Cancer Res 2008,6(8),1308-1315","journal-title":"Mol Cancer Res"},{"key":"ref=22e","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/neuonc\/nor077","volume":"13","author":"Bai R.Y.","year":"2011","unstructured":"Bai R.Y.; Staedtke V.; Aprhys C.M.; Gallia G.L.; Riggins G.J.; Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neuro-oncol 2011,13(9),974-982","journal-title":"Neuro-oncol"},{"key":"ref=23a","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2298\/APT0435231P","volume":"35","author":"Podunavac-Kuzmanovi\u0107 S.O.","year":"2004","unstructured":"Podunavac-Kuzmanovi\u0107 S.O.; Cvetkovi\u0107 D.M.; \u0106etkovi\u0107 G.S.; Antimicrobial activity of cobalt (II) complexes with 2-aminobenzimidazole derivatives. APTEFF 2004,35,231-237","journal-title":"APTEFF"},{"key":"ref=23b","first-page":"75","volume":"11","author":"Kukalenko S.S.","year":"1991","unstructured":"Kukalenko S.S.; Udovenko V.A.; Borysova V.P.; Kulugina N.L.; Burmakin N.M.; Andreeva E.L.U.S.S.R.; SU 1,636,414. Odkrytiya Izobret 1991,11,75","journal-title":"Odkrytiya Izobret"},{"key":"ref=23c","author":"Esser F.","year":"1999","unstructured":"Esser F.; Schonnenberg G.; Dollinger H.; Geida W.;  Ger Offen DE 1999","journal-title":"Ger Offen DE"},{"key":"ref=24","first-page":"758","volume":"51","author":"Nikolova A.","year":"2001","unstructured":"Nikolova A.; Ivanov D.; Buyukliev R.; Konstantinov S.; Karaivanova M.; Preparation, physicochemical characterization and pharmacological study of novel ruthenium(III) complexes with imidazole and benzimidazole derivatives. Arzneimittelforschung 2001,51(9),758-762","journal-title":"Arzneimittelforschung"},{"key":"ref=25","first-page":"7642265B2","author":"Seth P.P.","year":"2009","unstructured":"Seth P.P.; Jefferson E.A.; Griffey R.H.; Swayze E.E.; Benzimidazoles and analogs thereof as antivirals PCT Int. Appl 2009,7642265B2","journal-title":"Appl"},{"key":"ref=26a","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1021\/jm050815o","volume":"48","author":"Seth P.P.","year":"2005","unstructured":"Seth P.P.; Miyaji A.; Jefferson E.A.; Sannes-Lowery K.A.; Osgood S.A.; Propp S.S.; Ranken R.; Massire C.; Sampath R.; Ecker D.J.; Swayze E.E.; Griffey R.H.; SAR by MS: Discovery of a new class of RNA-binding small molecules for the hepatitis C virus: Internal ribosome entry site IIA subdomain. J Med Chem 2005,48(23),7099-7102","journal-title":"J Med Chem"},{"key":"ref=26b","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1021\/ci500132c","volume":"54","author":"Henriksen N.M.","year":"2014","unstructured":"Henriksen N.M.; Hayatshahi H.S.; Davis D.R.; Cheatham T.E.; III Structural and energetic analysis of 2-aminobenzimidazole inhibitors in complex with the hepatitis C virus IRES RNA using molecular dynamics simulations. J Chem Inf Model 2014,54(6),1758-1772","journal-title":"J Chem Inf Model"},{"key":"ref=27a","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1021\/jo9010552","volume":"74","author":"Alma&#x15F;i D.","year":"2009","unstructured":"Alma&#x15F;i D.; Alonso D.A.; G&#xF3;mez-Bengoa E.; N&#xE1;jera C.; Chiral 2-aminobenzimidazoles as recoverable organocatalysts for the addition of 1,3-dicarbonyl compounds to nitroalkenes. J Org Chem 2009,74(16),6163-6168","journal-title":"J Org Chem"},{"key":"ref=27b","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1021\/ol202599h","volume":"13","author":"G&#xF3;mez-Torres E.","year":"2011","unstructured":"G&#xF3;mez-Torres E.; Alonso D.A.; G&#xF3;mez-Bengoa E.; N&#xE1;jera C.; Conjugate addition of 1,3-dicarbonyl compounds to maleimides using a chiral C2-symmetric bis(2-aminobenzimidazole) as recyclable organocatalyst. Org Lett 2011,13(22),6106-6109","journal-title":"Org Lett"},{"key":"ref=27c","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/ejoc.201201046","volume":"2013","author":"G&#xF3;mez-Torres E.","year":"2013","unstructured":"G&#xF3;mez-Torres E.; Alonso D.A.; G&#xF3;mez-Bengoa E.; N&#xE1;jera C.; Enantioselective synthesis of succinimides by michael addition of1,3-dicarbonyl compounds to maleimides catalyzed by a chiral bis(2-aminobenzimidazole) organocatalyst. Eur J Org Chem 2013,2013(8),1434-1440","journal-title":"Eur J Org Chem"},{"key":"ref=27d","first-page":"1","volume":"8","author":"N&#xE1;jera C.","year":"2016","unstructured":"N&#xE1;jera C.; Yus M.; Chiral Benzimidazoles as Hydrogen Bonding Organocatalysts., Tetrahedron Lett. 2015, 56, 2623-2633. (f) Trillo, P.; G&#xF3;mez-Mart&#xED;nez, M.; Alonso D. A.; Baeza, A. 2-Aminobenzimidazole Organocatalyzed Asymmetric Amination of Cyclic 1,3-Dicarbonyl Compounds., Synlett2015, 26, 95-100. (g) Serrano-S&#xE1;nchez, D.; Baeza A. and Alonso, D. A. Organocatalytic Asymmetric &#x3B1;-Chlorination of 1,3-Dicarbonyl Compounds Catalyzed by 2-Aminobenzimidazole Derivatives. Symmetry (Basel) 2016,8,1-12","journal-title":"Symmetry (Basel)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.3390\/molecules190913878","volume":"19","author":"Cruz A.","year":"2014","unstructured":"Cruz A.; Padilla-Mart&#xED;nez I.I.; Garc&#xED;a-B&#xE1;ez E.V.; Guerrero-Mu&#xF1;oz G.; Synthesis and structure of sulfur derivatives from 2-aminobenzimidazole. Molecules 2014,19(9),13878-13893","journal-title":"Molecules"},{"key":"ref=29a","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/cr60151a002","volume":"48","author":"Wright J.B.","year":"1951","unstructured":"Wright J.B.; The chemistry of the benzimidazoles. Chem Rev 1951,48(3),397-541","journal-title":"Chem Rev"},{"key":"ref=29b","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","volume":"97","author":"Yadav G.","year":"2015","unstructured":"Yadav G.; Ganguly S.; Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review. Eur J Med Chem 2015,97,419-443","journal-title":"Eur J Med Chem"},{"key":"ref=29c","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jscs.2016.08.001","volume":"21","author":"Alaqueel Sh.I.","year":"2017","unstructured":"Alaqueel Sh.I.; Synthetic Approaches to Benzimidazoles from o-Phenylenediamine: A literature review. J Saudi Chem Soc 2017,21(2),229-237","journal-title":"J Saudi Chem Soc"},{"key":"ref=29d","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ejmech.2016.12.010","volume":"126","author":"Akhtar W.","year":"2017","unstructured":"Akhtar W.; Khan M.F.; Verma G.; Shaquiquzzaman M.; Rizvi M.A.; Mehdi S.H.; Akhter M.; Alam M.M.; Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. Eur J Med Chem 2017,126,705-753","journal-title":"Eur J Med Chem"},{"key":"ref=29e","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/molecules26092684","volume":"26","author":"Hadole C.D.","year":"2021","unstructured":"Hadole C.D.; Rajput J.D.; Bendre R.S.; Concise on Some Biologically Important 2-Substituted Benzimidazole Derivatives., Org. Chem. Curr. Res. 2018, 7 (3), 1-9. f) Saber, A.; Sebbara, N.K.; Essassia, El M. Synthesis, Reactivities and Biolobical Properties of Benzimidazole Derivatives., J. Mar. Chim. Heterocycl. 2019, 18, 1-50. g) Vasavaa, M.S.; Rathwaa, S.K.; Jethavaa, D.J.; Acharyaa, P.T.; Patela, D.B. and Patel, H.D. Benzimidazole: A Milestone in the Field of Medicinal Chemistry., Mini-Rev. Med. Chem. 2020, 20, 532-565. h) Tahlan, S.; Kumar, S. and Narasimhan, B. Pharmacological Significance of Heterocyclic 1H-Benzimidazole Scaffolds: A Review., BMC Chem. 2019, 13:101. i) Singhal, S.; Khanna, P.; Panda, S.S.; Khanna, L. Recent Trends in the Synthesis of Benzimidazoles From o-Phenylenediamine via Nanoparticles and Green Strategies Using Transition Metal Catalysts., J. Heterocyclic Chem. 2019, 56, 2702-2729. j) Manna, S.K.; Das, T.; Samanta, Sh. &#x201C;Polycyclic Benzimidazole: Synthesis and Photophysical Properties., Chemistry Select2019, 4, 8781-8790. k) Faheem, M.; Rathaur, A.; Pandey, A.; Singh, V.K. and Tiwari, A.K. A Review on the Modern Synthetic Approach of Benzimidazole Candidate., Chem. Select2020, 5, 3981-3994. l) Padhy, G.K.; Panda, J.; Raul, S.K.; Behera, A.K. 2-Acetylbenzimidazole: a Valuable Synthon for the synthesis of Biologically Active Molecules., Biointerface Res. App. Chem. 2021, 11, 11562-11591. m) Sweeney, M.; Conboy, D.; Mirallai, S.I. and Aldabbagh, F. Advances in the Synthesis of Ring-Fused Benzimidazoles and Imidazobenzimidazoles. Molecules 2021,26,2684","journal-title":"Molecules"},{"key":"ref=30","first-page":"705","author":"Simonov A.M.","year":"1980","unstructured":"Simonov A.M.; Anisimova V.A.;  Synthesis and transformation of 2-Aminobenzimidazoles (review) 1980,705-723","journal-title":"Synthesis and transformation of 2-Aminobenzimidazoles (review)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1055\/s-1983-30546","volume":"11","author":"Rastogi R.","year":"1983","unstructured":"Rastogi R.; Sharma S.; 2-Aminobenzimidazoles in organic syntheses. Synthesis 1983,11(11),861-882","journal-title":"Synthesis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ejmech.2006.01.002","volume":"41","author":"Guida X.","year":"2006","unstructured":"Guida X.; Jianhua H.; Xiaomin L.; Synthesis and QSAR studies of novel 1-substituted-2-aminobenzimidazoles derivatives. Eur J Med Chem 2006,41(9),1080-1083","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ejmech.2013.01.026","volume":"62","author":"Di Braccio M.","year":"2013","unstructured":"Di Braccio M.; Grossi G.; Signorello M.G.; Leoncini G.; Cichero E.; Fossa P.; Alfei S.; Damonte G.; Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones. Eur J Med Chem 2013,62,564-578","journal-title":"Eur J Med Chem"},{"key":"ref=34","first-page":"181","volume":"6","author":"Rao S.S.","year":"2016","unstructured":"Rao S.S.; An eco-friendly synthesis of N-alkyl-2-aminobenzimidazole. Heterocyclic Lett 2016,6,181-184","journal-title":"Heterocyclic Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1016\/j.bmc.2013.05.001","volume":"21","author":"Zhu J.","year":"2013","unstructured":"Zhu J.; Wu C.F.; Li X.; Wu G.S.; Xie S.; Hu Q.N.; Deng Z.; Zhu M.X.; Luo H-R.; Hong X.; Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase. Bioorg Med Chem 2013,21(14),4218-4224","journal-title":"Bioorg Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1021\/jm021043o","volume":"47","author":"Ramstr&#xF6;m H.","year":"2004","unstructured":"Ramstr&#xF6;m H.; Bourotte M.; Philippe C.; Schmitt M.; Haiech J.; Bourguignon J-J.; Heterocyclic bis-cations as starting hits for design of inhibitors of the bifunctional enzyme histidine-containing protein kinase\/phosphatase from bacillus subtilis. J Med Chem 2004,47(9),2264-2275","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1016\/j.ejmech.2011.04.061","volume":"46","author":"Mavrova A.Ts.","year":"2011","unstructured":"Mavrova A.Ts.; Wesselinova D.; Vassilev N.; Tsenov J.A.; Synthesis, characterization and cytotoxicity of some novel 1,3-disubstituted-2,3-dihydro-2-iminobenzimidazoles. Eur J Med Chem 2011,46(8),3362-3367","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ejmech.2013.03.010","volume":"63","author":"Mavrova A.Ts.","year":"2013","unstructured":"Mavrova A.Ts.; Wesselinova D.; Vassilev N.; Tsenov J.A.; Design, synthesis and antiproliferative properties of some new 5-substituted-2-iminobenzimidazole derivatives. Eur J Med Chem 2013,63,696-701","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1016\/j.bmc.2015.08.029","volume":"23","author":"Mavrova A.Ts.","year":"2015","unstructured":"Mavrova A.Ts.; Yancheva D.; Anastassova N.; Anichina K.; Zvezdanovic J.; Djordjevic A.; Markovic D.; Smelcerovic A.; Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles. Bioorg Med Chem 2015,23(19),6317-6326","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/molecules22040579","volume":"22","author":"Hern&#xE1;ndez-N&#xFA;&#xF1;ez E.","year":"2017","unstructured":"Hern&#xE1;ndez-N&#xFA;&#xF1;ez E.; Tlahuext H.; Moo-Puc R.; Moreno D.; Gonz&#xE1;lez-D&#xED;az M.O.; V&#xE1;zquez G.N.; Design, synthesis and biological evaluation of 2-(2-Amino-5(6)-nitro-1H-benzimidazol-1-yl)-N-arylacetamides as Antiprotozoal Agents. Molecules 2017,22(4),579","journal-title":"Molecules"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.bmcl.2006.11.090","volume":"17","author":"Holloway G.A.","year":"2007","unstructured":"Holloway G.A.; Baell J.B.; Fairlamb A.H.; Novello P.M.; Parisot J.P.; Richardson J.; Watson K.G.; Street I.P.; Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening. Bioorg Med Chem Lett 2007,17(5),1422-1427","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1023\/A:1022498224975","volume":"36","author":"Anisimova V.A.","year":"2002","unstructured":"Anisimova V.A.; Spasov A.A.; Kucheryavenko A.F.; Panchenko T.I.; Ostrovskii O.V.; Kosolapov V.A.; Larionov N.P.; Synthesis and pharmacological activity of 2-(hetaryl)imidazo[1,2-a]benzimidazoles. Pharm Chem J 2002,36(10),528-534","journal-title":"Pharm Chem J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11094-006-0105-8","volume":"40","author":"Simova V.A.","year":"2006","unstructured":"Simova V.A.; Tolpygin I.E.; Spasov A.A.; Kosolapov V.A.; Stepanov A.V.; Kucheryavenko A.F.; Synthesis and biological activity of n-acylmethyl derivatives of 9H-2,3-dihydroimidazoand 10H-2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazoles and their reduction products. Pharm Chem J 2006,40(5),261-267","journal-title":"Pharm Chem J"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11094-006-0185-5","volume":"40","author":"Anisimova V.A.","year":"2006","unstructured":"Anisimova V.A.; Spasov A.A.; Kosolapov V.A.; Chernikov M.V.; Stukovina A.Yu.; El\u2019tsova L.V.; Larionov N.P.; Libinzon R.E.; Vatolkina O.E.; Synthesis and biological activity of 9-dialkylaminoethyl-2-oxy(dioxy)-phenylimidazo[1,2-a]benzimidazoles. Pharm Chem J 2006,40(10),521-529","journal-title":"Pharm Chem J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11094-010-0465-y","volume":"44","author":"Anisimova V.A.","year":"2010","unstructured":"Anisimova V.A.; Spasov A.A.; Tolpygin I.E.; Minkin V.I.; Chernikov M.V.; Yakovlev D.S.; Stukovina A.Yu.; Goryagin I.I.; Grechko O.Y.; Kirillova N.V.; Kosolapov V.A.; Tibir\u2019kova E.V.; Salaznikova O.A.; Naumenko L.V.; Gurova N.A.; Synthesis and pharmacological activity of 9-R-2-halogenophenylimidazo[1,2-a]benzimidazoles. Pharm Chem J 2010,44(7),345-351","journal-title":"Pharm Chem J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1134\/S1070428011090156","volume":"47","author":"Anisimova V.A.","year":"2011","unstructured":"Anisimova V.A.; Tolpygin E.I.; Imidazo[1,2-a]benzimidazole derivatives: XXVIII. Syntheses and heterocyclizations on the basis of 1-Allyl-2-aminobenzimidazole. Russ J Org Chem 2011,47(9),1346-1353","journal-title":"Russ J Org Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1134\/S1070428011090168","volume":"47","author":"Anisimova V.A.","year":"2011","unstructured":"Anisimova V.A.; Tolpygin E.I.; Imidazo[1,2-a]benzimidazole derivatives: XXIX. 1-Allyl-2-amino-3-acylmethylbenzimidazolium halides and syntheses on their base. Russ J Org Chem 2011,47(9),1354-1361","journal-title":"Russ J Org Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ejmech.2014.07.038","volume":"84","author":"Oh S.","year":"2014","unstructured":"Oh S.; Kim S.; Kong S.; Yang G.; Lee N.; Han D.; Goo J.; Siqueira-Neto J.L.; Freitas-Junior L.H.; Song R.; Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi. Eur J Med Chem 2014,84,395-403","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1023\/A:1021888520874","volume":"36","author":"Anisinova V.A.","year":"2002","unstructured":"Anisinova V.A.; Osipova M.M.; Spasov A.A.; Turchaeva A.F.; Dudchenko G.P.; Larionov N.P.; Kovalev S.G.; Synthesis and pharmacological activity of 1-n- and 10-n-substituted-1(10),2,3,4-tetrahydropyrimido-[1,2-a]benzimidazoles. Pharm Chem J 2002,36(9),468-473","journal-title":"Pharm Chem J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1128\/AAC.48.5.1749-1755.2004","volume":"48","author":"Kern E.R.","year":"2004","unstructured":"Kern E.R.; Hartline C.B.; Rybak R.J.; Drach J.C.; Townsend L.B.; Biron K.K.; Bidanset D.J.; Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections. Antimicrob Agents Chemother 2004,48,1749-1755","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-0-387-31047-3_11","author":"Biron K.K.","year":"2006","unstructured":"Biron K.K.;  New concepts of antiviral therapy 2006,309","journal-title":"New concepts of antiviral therapy"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1345\/aph.1L065","volume":"42","author":"Trofe J.","year":"2008","unstructured":"Trofe J.; Pote L.; Wade E.; Blumberg E.; Bloom R.D.; Maribavir: A novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother 2008,42(10),1447-1457","journal-title":"Ann Pharmacother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/9780470929353.ch29","author":"Biron K.K.","year":"2011","unstructured":"Biron K.K.; Gudmundsson K.S.; Drach J.C.;  Antiviral drugs: From basic discovery throught clinical trials 2011,417","journal-title":"Antiviral drugs: From basic discovery throught clinical trials"},{"key":"ref=54","author":"Peabody J.D.","year":"2012","unstructured":"Peabody J.D.; Maribavir isomers, compositions, methods of making and methods of using. 20120283210, 2012"},{"key":"ref=55","volume":"6,077,832A","author":"Chamberlain S.D.","year":"2000","unstructured":"Chamberlain S.D.; Daluge S.M.; Koszalka G.W.; Antiviral benzimidazole nucleoside analogues and method for their preparation. Glaxo Wellcome Inc 2000,6,077,832A","journal-title":"Glaxo Wellcome Inc"},{"key":"ref=56","first-page":"7,858,773","author":"Freeman S.","year":"2010","unstructured":"Freeman S.; Wycombe H.;  GlaxoSmithKline 2010,7,858,773","journal-title":"GlaxoSmithKline"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0960-894X(00)80628-96204249","volume":"2","author":"Devivar R.V.","year":"1992","unstructured":"Devivar R.V.; Drach J.C.; Townsend L.B.; Benzimidazole ribonucleosides: Observation of an unexpected nitration when performing non-aqueous diazotizations with t-butyl nitrite. Bioorg Med Chem Lett 1992,2(9),1105-1110","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.coviro.2011.10.015","volume":"1","author":"Price N.B.","year":"2011","unstructured":"Price N.B.; Prichard M.N.; Progress in the development of new therapies for herpesvirus infections. Curr Opin Virol 2011,1(6),548-554","journal-title":"Curr Opin Virol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"12108","DOI":"10.1128\/JVI.01575-09","volume":"83","author":"Wang F-Z.","year":"2009","unstructured":"Wang F-Z.; Roy D.; Gershburg E.; Whitehurst C.B.; Dittmer D.P.; Pagano J.S.; Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication. J Virol 2009,83(23),12108-12117","journal-title":"J Virol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1128\/AAC.47.7.2186-2192.2003","volume":"47","author":"Williams S.L.","year":"2003","unstructured":"Williams S.L.; Hartline C.B.; Kushner N.L.; Harden E.A.; Bidanset D.J.; Drach J.C.; Townsend L.B.; Underwood M.R.; Biron K.K.; Kern E.R.; In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob Agents Chemother 2003,47(7),2186-2192","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2165\/00126839-200708030-00006","volume":"8","year":"2007","unstructured":"Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263. Drugs R D 2007,8(3),188-192","journal-title":"Drugs R D"},{"key":"ref=62","author":"Jhon D.P.","year":"2015","unstructured":"Jhon D.P.; Maribavir isomers, compositions, methods of making and methods of using. 8940707 2015","journal-title":"8940707"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1182\/blood-2007-11-121558","volume":"111","author":"Winston D.J.","year":"2008","unstructured":"Winston D.J.; Young J.A.; Pullarkat V.; Papanicolaou G.A.; Vij R.; Vance E.; Alangaden G.J.; Chemaly R.F.; Petersen F.; Chao N.; Klein J.; Sprague K.; Villano S.A.; Boeckh M.; Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 2008,111(11),5403-5410","journal-title":"Blood"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1399-3062.2010.00550.x","volume":"12","author":"Avery R.K.","year":"2010","unstructured":"Avery R.K.; Marty F.M.; Strasfeld L.; Lee I.; Arrieta A.; Chou S.; Tatarowicz W.; Villano S.; Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transpl Infect Dis 2010,12(6),489-496","journal-title":"Transpl Infect Dis"},{"key":"ref=65","unstructured":"No authors listed. Efficacy and safety study of maribavir treatment compared to investigator-assigned treatment in transplant recipients with cytomegalovirus (cmv) infections that are refractory or resistant to treatment with ganciclovir, valganciclovir, foscarnet, or cidofovir&#x201D;  https:\/\/clinicaltrials.gov\/show\/NCT029315392017"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1850358","volume":"38","author":"Martin M.M.","year":"2020","unstructured":"Martin M.M.; Uzzaman M.; Chowdhury S.A.; Bhuiyan M.M.H.; In vitro antimicrobial, physicochemical, pharmacokinetics, and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease. J Biomol Struct Dyn 2020,38,1-13","journal-title":"J Biomol Struct Dyn"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/15257779908041486","volume":"18","author":"Townsend L.B.","year":"1999","unstructured":"Townsend L.B.; Gudmundsson K.S.; Daluge S.M.; Chen J.J.; Zhu Z.; Koszalka G.W.; Boyd L.; Chamberlain S.D.; Freeman G.A.; Biron K.K.; Drach J.C.; Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB. Nucleosides Nucleotides 1999,18(4-5),509-519","journal-title":"Nucleosides Nucleotides"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.bmcl.2017.03.100","volume":"27","author":"Kharitonova M.I.","year":"2017","unstructured":"Kharitonova M.I.; Denisova A.O.; &#xC1;ndronova V.L.A.; Kayushin A.L.; Konstantinova I.D.; Kotovskaya S.K.; Galegov G.A.; Charushin V.N.; Miroshnikov A.I.; New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1. Bioorg Med Chem Lett 2017,27(11),2484-2487","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0011-393X(04)90008-2","volume":"65","author":"Terzano C.","year":"2004","unstructured":"Terzano C.; Petroianni A.; Ricci A.; Herpes simplex pneumonia: Combination therapy with oral acyclovir and aerosolized ribavirin in an immunocompetent patient. Curr Ther Res Clin Exp 2004,65(1),90-96","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000237969","volume":"27","author":"Bierman S.M.","year":"1981","unstructured":"Bierman S.M.; Kirkpatrick W.; Fernandez H.; Clinical efficacy of ribavirin in the treatment of genital herpes simplex virus infection. Chemotherapy 1981,27(2),139-145","journal-title":"Chemotherapy"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"10364","DOI":"10.1002\/anie.201204710","volume":"51","author":"Ueda S.","year":"2012","unstructured":"Ueda S.; Buchwald S.L.; Catalyst-controlled chemoselective arylation of 2-aminobenzimidazoles. Angew Chem Int Ed Engl 2012,51(41),10364-10367","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1039\/C6OB01307D","volume":"14","author":"Kumar K.A.","year":"2016","unstructured":"Kumar K.A.; Kannaboina P.; Rao D.N.; Das P.; Nickel-catalyzed Chan-Lam cross-coupling: Chemoselective N-arylation of 2-aminobenzimidazoles. Org Biomol Chem 2016,14(38),8989-8997","journal-title":"Org Biomol Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1080\/00397911.2011.567883","volume":"42","author":"Servi S.","year":"2012","unstructured":"Servi S.; Genc M.; Microwave-Assisted synthesis of N-(1H-Imidazoline-2-yl)-1H-benzimidazol-2-amine and Its N-Functionalized Derivatives. Synth Commun 2012,42(19),2797-2805","journal-title":"Synth Commun"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1016\/j.bmc.2007.06.017","volume":"15","author":"Mavrova A.Ts.","year":"2007","unstructured":"Mavrova A.Ts.; Denkova P.; Tsenov Y.A.; Anichina K.K.; Vutchev D.I.; Synthesis and antitrichinellosis activity of some bis(benzimidazol-2-yl)amines. Bioorg Med Chem 2007,15(18),6291-6297","journal-title":"Bioorg Med Chem"},{"key":"ref=75","author":"Mavrova A.T.","year":"2012","unstructured":"Mavrova A.T.; Wesselinova D.; Tsenov J.A.; Denkova P.;  Cytotoxic effects of some N-Substituted-2-Amino-1H-Benzimidazoles 2012","journal-title":"Cytotoxic effects of some N-Substituted-2-Amino-1H-Benzimidazoles"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1002\/ejoc.201200698","volume":"2012","author":"Li F.","year":"2012","unstructured":"Li F.; Kang Q.; Shan H.; Chen L.; Xie J.; Regioselective N-Alkylation of 2-Aminoimidazoles with alcohols to 2-(NAlkylamino)imidazoles catalyzed by the [Cp*IrCl2]2\/K2CO3 System. Eur J Org Chem 2012,2012(26),5085-5092","journal-title":"Eur J Org Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1016\/j.bmc.2016.09.036","volume":"24","author":"Zarubaev V.V.","year":"2016","unstructured":"Zarubaev V.V.; Morkovnik A.S.; Divaeva L.N.; Karpinskaya L.A.; Borodkin G.S.; Borodkin G.S.; Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study. Bioorg Med Chem 2016,24(22),5796-5803","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0223-5234(98)80027-5","volume":"33","author":"Da Settimo A.","year":"1998","unstructured":"Da Settimo A.; Da Settimo F.; Marini A.M.; Primofiore G.; Salerno S.; Viola S.; Lisa Dalla Via L.D.; Magno S.M.; Synthesis, DNA Binding and in Vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents. Eur J Med Chem 1998,33(9),685-696","journal-title":"Eur J Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ejmech.2007.03.005","volume":"42","author":"Li Y-F.","year":"2007","unstructured":"Li Y-F.; Wang G-F.; Luo Y.; Huang W-G.; Tang W.; Feng C.L.; Shi L-P.; Ren Y-D.; Zuo J-P.; Lu W.; Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus. Eur J Med Chem 2007,42(11-12),1358-1364","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3987\/COM-06-10844","volume":"68","author":"Starcevic K.","year":"2006","unstructured":"Starcevic K.; Caleta I.; Cincic D.; Kaitner B.; Kralj M.; Ester K.; Karminski-Zamola G.; Synthesis, crystal structure determination and antiproliferative evaluation of novel benzazoyl benzamides. Heterocycles 2006,68(11),2285-2289","journal-title":"Heterocycles"},{"key":"ref=81","first-page":"196","volume":"2","author":"Babu G.S.","year":"2010","unstructured":"Babu G.S.; Rajani N.; Malathy P.S.; Srinivas B.; Kulandaivelu U.; Rao J.V.; Synthesis, characterization and evaluation of Novel N-(1H-Benzimidazol-2-yl)-2-isatinylidene-hydrazinecarboxamide derivatives as Anti-Inflammatory agents. Scholars Research Library 2010,2(3),196-204","journal-title":"Scholars Research Library"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"126871","DOI":"10.1016\/j.molstruc.2019.126871","volume":"1198","author":"Babu K.N.","year":"2019","unstructured":"Babu K.N.; Nagarjuna U.; Reddy G.D.; Padmaja A.; Padmavathi V.; Synthesis and antimicrobial activity of benzazolyl azolyl urea derivatives. J Mol Struct 2019,1198,126871","journal-title":"J Mol Struct"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1016\/j.bmcl.2014.07.035","volume":"24","author":"Wang W.","year":"2014","unstructured":"Wang W.; Kong D.; Cheng H.; Tan L.; Zhang Z.; Zhuang X.; Long H.; Zhou Y.; Xu Y.; Yang X.; Ding K.; New benzimidazole-2-urea derivates as tubulin inhibitors. Bioorg Med Chem Lett 2014,24(17),4250-4253","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1021\/jm701456r","volume":"51","author":"Chassaing C.","year":"2008","unstructured":"Chassaing C.; Berger M.; Heckeroth A.; Ilg T.; Jaeger M.; Kern C.; Schmid K.; Uphoff M.; Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: Synthesis, pharmacodynamics, and pharmacokinetics. J Med Chem 2008,51(5),1111-1114","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ejmech.2017.05.014","volume":"136","author":"Cindri\u0107 M.","year":"2017","unstructured":"Cindri\u0107 M.; Jambon S.; Harej A.; Depauw S.; David-Cordonnier M-H.; Kraljevi\u0107 Paveli\u0107 S.; Karminski-Zamola G.; Hranjec M.; Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties. Eur J Med Chem 2017,136,468-479","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1039\/p19760000309","author":"Katritzky A.R.","year":"1976","unstructured":"Katritzky A.R.; Yates F.; Phthaloylation of amino-azoles and aminoazines. J Chem Soc, Perkin Trans 1 1976(3),309-312","journal-title":"J Chem Soc, Perkin Trans 1"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bioorg.2018.05.014","volume":"80","author":"Kaur G.","year":"2018","unstructured":"Kaur G.; Silakari O.; Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation. Bioorg Chem 2018,80,24-35","journal-title":"Bioorg Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/BF02975257","volume":"25","author":"Nofal Z.M.","year":"2002","unstructured":"Nofal Z.M.; Fahmy H.H.; Mohamed H.S.; Synthesis, antimicrobial and molluscicidal activities of new benzimidazole derivatives. Arch Pharm Res 2002,25(1),28-38","journal-title":"Arch Pharm Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1016\/j.bmc.2017.09.045","volume":"25","author":"Abbhi V.","year":"2017","unstructured":"Abbhi V.; Saini L.; Mishra S.; Sethi G.; Kumar A.P.; Piplani P.; Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma. Bioorg Med Chem 2017,25(21),6071-6085","journal-title":"Bioorg Med Chem"},{"key":"ref=90a","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.bmcl.2006.03.020","volume":"16","author":"Powers J.P.","year":"2006","unstructured":"Powers J.P.; Li S.; Jaen J.C.; Liu J.; Walker N.P.C.; Wang Z.; Wesche H.; Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett 2006,16(11),2842-2845","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90b","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.molstruc.2019.05.102","volume":"1195","author":"Martin M.M.","year":"2019","unstructured":"Martin M.M.; Bhuiyan M.M.H.; Kabir E.; Sanaullah A.F.M.; Rahman M.A.; Hossain M.E.; Uzzaman M.; Synthesis, Characterization, ADMET, PASS predication, and antimicrobial study of 6-O-lauroyl mannopyranosides. J Mol Struct 2019,1195,189-197","journal-title":"J Mol Struct"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00044-014-1180-0","volume":"24","author":"Reddy L.M.","year":"2015","unstructured":"Reddy L.M.; Prakash T.B.; Padmaja A.; Padmavathi V.; Synthesis and antimicrobial activity of pyrazolyl benzoxazoles, benzothiazoles and benzimidazoles. Med Chem Res 2015,24(3),970-979","journal-title":"Med Chem Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.apsb.2014.07.001","volume":"4","author":"Arora R.K.","year":"2014","unstructured":"Arora R.K.; Kaur N.; Bansal Y.; Bansal G.; Novel coumarin-benzimidazole derivatives as antioxidants and safer anti-inflammatory agents. Acta Pharm Sin B 2014,4(5),368-375","journal-title":"Acta Pharm Sin B"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7780","DOI":"10.1039\/c2ob26299a","volume":"10","author":"Hiscock J.R.","year":"2012","unstructured":"Hiscock J.R.; Gale P.A.; Lalaoui N.; Light M.E.; Wells N.J.; Benzimidazole-based anion receptors exhibiting selectivity for lactate over pyruvate. Org Biomol Chem 2012,10(38),7780-7788","journal-title":"Org Biomol Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.bmc.2015.02.054","volume":"23","author":"He X.","year":"2015","unstructured":"He X.; Lakkaraju S.K.; Hanscom M.; Zhao Z.; Wu J.; Stoica B.; MacKerell A.D.; Faden A.I.; Xue F.; Acyl-2-aminobenzimidazoles: A novel class of neuroprotective agents targeting mGluR5. Bioorg Med Chem 2015,23(9),2211-2220","journal-title":"Bioorg Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jtumed.2016.05.004","volume":"11","author":"Aruna Sindhe M.M.","year":"2016","unstructured":"Aruna Sindhe M.M.; Bodke Y.D.; Kenchappa R.; Telkar S.; Chandrashekar A.; Vinoda B.M.; Catalytic assemble of 2-Amino-5,6-dimethyl-1H-benzimidazole with carboxylic acids and evaluation of their antimicrobial and antioxidant activities. J Taibah Univ Med Sci 2016,11,418-426","journal-title":"J Taibah Univ Med Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00044-014-1198-3","volume":"24","author":"Bansal Y.","year":"2015","unstructured":"Bansal Y.; Silakari O.; 2-Aminobenzimidazole conjugates of NSAIDS: Novel compounds with immunomodulatory, anti-inflammatory and antioxidant actions. Med Chem Res 2015,24(3),1170-1179","journal-title":"Med Chem Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1016\/j.tet.2012.09.071","volume":"68","author":"Tang G.","year":"2012","unstructured":"Tang G.; G&#xFC;n &#xDC;.; Altenbach H-J.; Altenbach, H.-J. Novel aminoimidazole derived proline organocatalysts for aldol reactions. Tetrahedron 2012,68(49),10230-10235","journal-title":"Tetrahedron"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2174\/15701808113109990028","volume":"10","author":"Mungu&#xED;a B.","year":"2013","unstructured":"Mungu&#xED;a B.; Mendina P.; Espinosa R.; Lanz A.; Salda&#xF1;a J.; Andina M.J.; Ures X.; L&#xF3;pez A.; Manta E.; Dom&#xED;nguez L.; Synthesis and anthelmintic evaluation of novel valerolactam benzimidazole hybrids. Lett Drug Des Discov 2013,10,1007-1014","journal-title":"Lett Drug Des Discov"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1016\/j.bmcl.2004.08.035","volume":"14","author":"Terzioglu N.","year":"2004","unstructured":"Terzioglu N.; van Rijn R.M.; Bakker R.A.; De Esch I.J.P.; Leurs R.; Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. Bioorg Med Chem Lett 2004,14(21),5251-5256","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/jhet.3569","volume":"56","author":"Sowdari J.","year":"2019","unstructured":"Sowdari J.; Gudi Y.; Donthamsetty S.V.; Venkatapuram P.; Adivireddy P.; Green approach for the synthesis of a new class of diamidomethane-linked benzazolyl pyrazoles and evaluation as antifungals. J Heterocycl Chem 2019,56(8),2080-2089","journal-title":"J Heterocycl Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/17518253.2018.1499968","volume":"11","author":"Kalhor M.","year":"2018","unstructured":"Kalhor M.; Banibairami S.; Mirshokraie S.A.; Ni@zeolite-Y Nanoporous; a valuable and efficient nanocatalyst for the synthesis of N-Benzimidazole-1,3-thiazolidinones. Green Chem Lett Rev 2018,11(3),334-344","journal-title":"Green Chem Lett Rev"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00044-016-1552-8","volume":"25","author":"Patil D.A.","year":"2016","unstructured":"Patil D.A.; Surana S.J.; Synthesis, biological evaluation of 2,3-disubstitutedimidazolyl\/benzimidazolyl-quinazolin-4(3H)-one derivatives. Med Chem Res 2016,25(6),1125-1139","journal-title":"Med Chem Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/jhet.3634","volume":"56","author":"Rajeswari T.","year":"2019","unstructured":"Rajeswari T.; Rekha T.; Reddy G.D.; Padmaja A.; Padmavathi V.; Synthesis and antibacterial activity of benzazolyl azolylsulfamoyl acetamides. J Heterocycl Chem 2019,56(9),2449-2459","journal-title":"J Heterocycl Chem"},{"key":"ref=104","first-page":"367","volume":"34","author":"Mobinikhaledi A.","year":"2010","unstructured":"Mobinikhaledi A.; Forughifar N.; Kalhor M.; An efficient synthesis of schiff bases containing benzimidazole moiety catalyzed by transition metal nitrates. Turk J Chem 2010,34,367-373","journal-title":"Turk J Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.ejmech.2011.03.008","volume":"46","author":"Hranjec M.","year":"2011","unstructured":"Hranjec M.; Star&#x10D;evi\u0107 K.; Paveli\u0107 S.K.; Lu&#x10D;in P.; Paveli\u0107 K.; Karminski Zamola G.; Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles. Eur J Med Chem 2011,46(6),2274-2279","journal-title":"Eur J Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.arabjc.2011.02.011","volume":"7","author":"Noolvi M.","year":"2014","unstructured":"Noolvi M.; Agrawal S.; Patel H.; Badiger A.; Gaba M.; Zambre A.; Synthesis, antimicrobial and cytotoxic activity of novel azetidine-2-one derivatives of 1H-benzimidazole. Arab J Chem 2014,7(2),219-226","journal-title":"Arab J Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.farmac.2003.12.001","volume":"59","author":"Nawrocka W.","year":"2004","unstructured":"Nawrocka W.; Sztuba B.; Kowalska M.W.; Liszkiewicz H.; Wietrzyk J.; Nasulewicz A.; Pe\u0142czy\u0144ska M.; Opolski A.; Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives. Farmaco 2004,59(2),83-91","journal-title":"Farmaco"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1016\/j.tetlet.2005.07.002","volume":"46","author":"Kang J.","year":"2005","unstructured":"Kang J.; Kim H.S.; Jang D.O.; Fluorescent anion chemosensors using 2-aminobenzimidazole receptors. Tetrahedron Lett 2005,46(36),6079-6082","journal-title":"Tetrahedron Lett"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1021\/jm800809f","volume":"51","author":"S&#xF8;rensen U.S.","year":"2008","unstructured":"S&#xF8;rensen U.S.; Str&#xF8;baek D.; Christophersen P.; Hougaard C.; Jensen M.L.; Nielsen E.&#xD8;.; Peters D.; Teuber L.; Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels. J Med Chem 2008,51(23),7625-7634","journal-title":"J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"25862","DOI":"10.1016\/j.matpr.2018.06.579","volume":"5","author":"Mangaveni P.","year":"2018","unstructured":"Mangaveni P.; Durga G.; Bhushanavathi P.; Sarada P.; Synthesis, characterization and their antimicrobial activity of crystalline materials of nickel (II) complexes with substituted 2-amino-benzimidazole. Mater Today Proc 2018,5(12),25862-25866","journal-title":"Mater Today Proc"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molstruc.2017.02.021","volume":"1137","author":"Joseph J.","year":"2017","unstructured":"Joseph J.; Suman A.; Nagashri K.; Joseyphus R.S.; Balakrishnan N.; Synthesis, characterization and biological studies of copper(ii) complexes with 2-aminobenzimidazole derivatives. J Mol Struct 2017,1137,17-26","journal-title":"J Mol Struct"},{"key":"ref=112","first-page":"415","volume":"258","author":"Horaka E.","year":"2018","unstructured":"Horaka E.; Kassala P.; Hranjec M.; Steinberg I.M. B;  2018,258,415-423"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00706-016-1796-5","volume":"147","author":"Sovic&#xB4; I.","year":"2016","unstructured":"Sovic&#xB4; I.; Orehovec I.; Stilinovic&#xB4; V.; Basaric&#xB4; N.; Karminski-Zamola G.; Benzothiazolyl- and benzimidazolyl-substituted 1-iminoisoindolines: Synthesis, mechanistic studies, and crystal structure determination. Monatsh Chem 2016,147(10),1825-1837","journal-title":"Monatsh Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.bmc.2018.02.045","volume":"26","author":"Sovi\u0107 I.","year":"2018","unstructured":"Sovi\u0107 I.; Jambon S.; Kraljevi\u0107 Paveli\u0107 S.; Markova-Car E.; Ili\u0107 N.; Depauw S.; David-Cordonnier M-H.; Karminski-Zamola G.; Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines. Bioorg Med Chem 2018,26(8),1950-1960","journal-title":"Bioorg Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1021\/ol070592r","volume":"9","author":"Singh N.","year":"2007","unstructured":"Singh N.; Jang D.O.; Benzimidazole-based tripodal receptor: Highly selective fluorescent chemosensor for iodide in aqueous solution. Org Lett 2007,9(10),1991-1994","journal-title":"Org Lett"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s12272-011-0903-8","volume":"34","author":"&#xD6;zkay Y.","year":"2011","unstructured":"&#xD6;zkay Y.; Tunal\u0131 Y.; Karaca H.; I&#x15F;\u0131kda&#x11F; I.; Antimicrobial activity of a new series of benzimidazole derivatives. Arch Pharm Res 2011,34(9),1427-1435","journal-title":"Arch Pharm Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/molecules23051232","volume":"23","author":"Hussain A.","year":"2018","unstructured":"Hussain A.; AlAjmi M.F.; Rehman M.T.; Khan A.A.; Shaikh P.A.; Khan R.A.; Evaluation of transition metal complexes of benzimidazole-derived scaffold as promising anticancer chemotherapeutics. Molecules 2018,23(5),1232","journal-title":"Molecules"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.saa.2015.03.020","volume":"147","author":"El-wakiel N.","year":"2015","unstructured":"El-wakiel N.; El-keiy M.; Gaber M.; Synthesis, spectral, antitumor, antioxidant and antimicrobial studies on Cu(II), Ni(II) and Co(II) complexes of 4-[(1H-Benzoimidazol-2-ylimino)-methyl]-benzene-1,3-diol. Spectrochim Acta A Mol Biomol Spectrosc 2015,147,117-123","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exppara.2017.11.009","volume":"184","author":"Nieto-Meneses R.","year":"2018","unstructured":"Nieto-Meneses R.; Castillo R.; Hern&#xE1;ndez-Campos A.; Maldonado-Rangel A.; Matius-Ruiz J.B.; Trejo-Soto P.J.; Nogueda-Torres B.; Dea-Ayuela M.A.; Bol&#xE1;s-Fern&#xE1;ndez F.; M&#xE9;ndez-Cuesta C.; Y&#xE9;pez-Mulia L.; In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Exp Parasitol 2018,184,82-89","journal-title":"Exp Parasitol"},{"key":"ref=120","author":"Javarishir S.F.","year":"2010","unstructured":"Javarishir S.F.; Afacile three-component one-pot solvent-free synthesis of 2&#xB4;-aminobenzimidazolomethylnaphthols. 14th International conference on synthetic organic chemistry ECSOC-14 2010","journal-title":"14th International conference on synthetic organic chemistry ECSOC-14"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1039\/C6NJ04074H","volume":"41","author":"Yarie M.","year":"2017","unstructured":"Yarie M.; Mohammad Ali Zolfigol M.A.; Baghery S.; Alonso D.A.; Khoshnood A.; Kalhor M.; Bayatd Y.; Asgarid A.; Design and preparation of [4,40-bipyridine]-1,10-diium trinitromethanide (BPDTNM) as a novel nanosized ionic liquid catalyst: Application to the synthesis of 1-(benzoimidazolylamino)methyl-2-naphthols. New J Chem 2017,41,4431-4440","journal-title":"New J Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1055\/s-0034-1380154","volume":"47","author":"Eleftheriadis N.","year":"2015","unstructured":"Eleftheriadis N.; Kasapidou P.M.; Stephanidou-Stephanatou J.; Tsoleridis C.A.; Hadjipavlou-Litina D.J.; Kontogiorgis C.; Pritsa A.; Papadopoulos A.; One-Pot Synthesis of highly functionalized benzimidazolylisophthalates and (2E)-2-Ethylidene-(1H)-pyridinecarboxylates by ultrasound-promoted multicomponent reactions. Synthesis 2015,47(10),1390-1398","journal-title":"Synthesis"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.1021\/ja9024676","volume":"131","author":"Rogers S.A.","year":"2009","unstructured":"Rogers S.A.; Huigens R.W.; Melander C.; A 2-aminobenzimidazole that inhibits and disperses gram-positive biofilms through a zinc-dependent mechanism. J Am Chem Soc 2009,131(29),9868-9869","journal-title":"J Am Chem Soc"},{"key":"ref=124","first-page":"305","volume":"50","author":"Srivastava P.K.","year":"1981","unstructured":"Srivastava P.K.; Upadhyaya J.S.; Gupta M.B.; Synthesis and antithyroid activity of some benzimidazolyl and benzenesulphonyl thiocarbamides. Curr Sci 1981,50,305-307","journal-title":"Curr Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mencom.2007.06.014","volume":"17","author":"Morkovnik A.S.","year":"2007","unstructured":"Morkovnik A.S.; Divaeva L.N.; Nelyubina Y.V.; Lyssenko K.A.; Vasilchenko I.S.; Structure and tautomerism of 2-benzimidazolylthioureas. Mendeleev Commun 2007,17(4),224-226","journal-title":"Mendeleev Commun"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11224-010-9632-8","volume":"21","author":"S\u2019miechowska A.","year":"2010","unstructured":"S\u2019miechowska A.; Przychodzen&#xB4; W.; Chojnacki J.; Bruz\u2019dziak P.; Namies\u2019nik J.; Bartoszek A.; Synthesis and structural characterization of novel 2-benzimidazolylthioureas: Adducts of natural isothiocyanates and 2-amino-1-methylbenzimidazole. Struct Chem 2010,21(5),955-964","journal-title":"Struct Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"130566","DOI":"10.1016\/j.molstruc.2021.130566","volume":"1241","author":"Lafzi F.","year":"2021","unstructured":"Lafzi F.; Kilic D.; Yildiz M.; Saracoglu N.; Design, synthesis, antimicrobial evaluation, and molecular docking of novel chiral urea\/thiourea derivatives bearing indole, benzimidazole, and benzothiazole scaffolds. J Mol Struct 2021,1241,130566","journal-title":"J Mol Struct"},{"key":"ref=128","first-page":"53","volume":"69","author":"Bhrigu B.","year":"2012","unstructured":"Bhrigu B.; Siddiqui N.; Pathak D.; Alam M.S.; Ali R.; Azad B.; Anticonvulsant evaluation of some newer benzimidazole derivatives: Design and synthesis. Acta Pol Pharm 2012,69(1),53-62","journal-title":"Acta Pol Pharm"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/0960-894X(95)00273-V","volume":"5","author":"Hamley P.","year":"1995","unstructured":"Hamley P.; Tinker A.C.; 1,2-Diaminobenzimidazoles: Selective inhibitors of nitric oxide synthase derived from aminoguanidine. Bioorg Med Chem Lett 1995,5(15),1573-1576","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00044-012-0220-x","volume":"22","author":"Murthy Y.L.N.","year":"2013","unstructured":"Murthy Y.L.N.; Durga G.; Jha A.; Synthesis, characterization, and antimicrobial activity of some new 2-diazo-benzimidazole derivatives and their Ni(II), Cu(II), and Ag(I) complexes. Med Chem Res 2013,22(5),2266-2272","journal-title":"Med Chem Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"128","DOI":"10.21123\/bsj.2016.13.2.2NCC.0128","volume":"13","author":"Abbas A.K.","year":"2016","unstructured":"Abbas A.K.; Preparation, characterization and biological evaluation of some lanthanide (iii) ions complexes with 3-(1-methyl-2-benzimidazolylazo)-tyrosine. Baghdad Sci J 2016,13(2),128-142","journal-title":"Baghdad Sci J"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0143-7208(99)00066-2","volume":"44","author":"Ertan N.","year":"1999","unstructured":"Ertan N.; Synthesis of some hetarylazopyrazolone dyes and solvent effects on their absorption spectra. Dyes Pigments 1999,44(1),41-48","journal-title":"Dyes Pigments"},{"key":"ref=133","first-page":"179","volume":"36","author":"Jain R.","year":"1987","unstructured":"Jain R.; Pandey P.; Synthesis and polarographic behaviour of (benzothiazolylazo)-pyrimidines. J Electrochem Soc India 1987,36,179-183","journal-title":"J Electrochem Soc India"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.dyepig.2005.05.003","volume":"70","author":"Sener I.","year":"2006","unstructured":"Sener I.; Karci F.; Ertan N.; Kilic E.; Synthesis and investigations of the absorption spectra of hetarylazo disperse dyes derived from 2,4-quinolinediol. Dyes Pigments 2006,70(2),143-148","journal-title":"Dyes Pigments"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.dyepig.2005.08.004","volume":"71","author":"Karci F.","year":"2006","unstructured":"Karci F.; Demircali A.; Synthesis of 4-amino-1Hbenzo[4,5]imidazo[1,2-a]pyrimidin-2-one and its disperse azo dyes. Part 2: Hetarylazo derivatives. Dyes Pigments 2006,71(2),97-102","journal-title":"Dyes Pigments"}],"container-title":["Current Organic Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179419666220310124223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202038\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179419666220310124223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:09:20Z","timestamp":1678709360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202038\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":176,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570179419666220310124223","relation":{},"ISSN":["1570-1794"],"issn-type":[{"value":"1570-1794","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}